Safe, pure, sustainable ingredients for life
Why Willow
We believe in challenging conventional methods to bring the benefits of nature to everyone. Your customers and your industry demand the safest, most pure active pharmaceutical ingredients (APIs) available. Few can deliver. We can. Beginning with Cannabigerol (CBG) and other cannabinoids, our leading biotechnology platform allows us to deliver consistent, economical, sustainable ingredients at a global scale.
Our Platform
Higher purity, lower cost
Plants are the best scientists. Using the instructions contained in the genes of therapeutic plants, we can produce the same compounds at higher purity, speed, consistency, and cost-effectiveness, but smaller environmental impact than traditional agriculture practices.
Our innovative research platform reinvents the production of active pharmaceutical ingredient (API) supplies for global pharmaceutical, health and wellness, and consumer packaged goods industries. Our current focus is on the production of pure CBG, with plans to target many more plant-sourced drugs in the future.
Products
About Us
Not everyone can do what we do. We are an elite team of scientists and business leaders pioneering how synthetic biology can bring the best of nature’s ingredients to market.
Management Team
Board of Directors
Strategically located facilities
We currently have facilities with over thirty science and technical staff in close proximity to allied university research and biotechnology hubs.
Please direct inquiries to our head office in Calgary, AB
Phone +1 403-910-5140
Email info@willowbio.com
Strategically located facilities
We currently have facilities with over thirty science and technical staff in close proximity to allied university research and biotechnology hubs.
Please direct inquiries to our head office in Calgary, AB
Email info@willowbio.com
Careers
We are game-changers and rule breakers. We shake things up, we discover, we create, we push boundaries and we deliver, always.
Investors
Based in Vancouver, British Columbia, Willow Biosciences is a biotechnology company focused on revolutionizing industrial manufacturing of active pharmaceutical ingredients and other high value products that have traditionally been derived from plants.
Current WLLW stock price
data currently unavailable
Press releases
All SEDAR fillingsAnalyst Coverage
David Kideckel, PhD MBA
AltaCorp Capital Inc.
+1 647-776-8240
dkideckel@Altacorpcapital.com
Ammar Shah
Eight Capital
+1 647-426-1665
ashah@viiicapital.com
News